Analysts expect Valion Bio, Inc. to report revenue of 1.37 M for Q4 24, against a range of 1.32 M to 1.42 M. The most recent reported quarter, Q3 25, came in at 146,000.00, a 69.1% miss against the 471,939.15 consensus.
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 376,000.00 | 161,000.00 | 282,000.00 | 356,000.00 | 334,000.00 | 140,000.00 | 126,000.00 | - | 70,000.00 | 86,000.00 | 146,000.00 | - | - | - | - | - |
| High Estimate | 558,208.33 | 614,566.08 | 775,914.40 | 1.36 M | 1.08 M | 1.25 M | 1.37 M | 1.42 M | 1.93 M | 601,607.07 | 506,539.84 | 5.35 M | 3.28 M | 854,398.22 | 543,490.61 | 14.75 M |
| Low Estimate | 460,196.07 | 575,321.22 | 697,716.20 | 1.17 M | 972,238.16 | 1.09 M | 1.23 M | 1.32 M | 1.70 M | 548,490.95 | 437,338.46 | 4.85 M | 2.77 M | 784,016.82 | 469,366.67 | 13.04 M |
| Consensus Estimate | 509,202.20 | 594,943.65 | 736,815.30 | 1.27 M | 1.03 M | 1.17 M | 1.30 M | 1.37 M | 1.82 M | 575,049.01 | 471,939.15 | 5.10 M | 3.03 M | 819,207.52 | 506,428.64 | 13.90 M |
Analysts expect Valion Bio, Inc. to report earnings per share of -2,268.54 for Q4 24, against a range of -2,376.15 to -2,160.93. The most recent reported quarter, Q4 25, came in at -62.11, a 98.3% beat against the -3,577.80 consensus.
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -4,670.00 | -2,980.00 | -629.00 | 3,860.00 | -429.25 | -136.00 | -97.75 | - | -62.96 | -54.81 | -49.14 | -62.11 |
| High Estimate | -4,132.54 | -3,391.52 | -3,007.35 | -2,683.13 | -2,641.68 | -2,607.18 | -2,330.96 | -2,160.93 | -269.44 | 1,929.07 | 1,556.47 | -3,460.32 |
| Low Estimate | -4,841.84 | -3,626.48 | -3,311.15 | -3,125.33 | -3,044.78 | -2,841.50 | -2,531.72 | -2,376.15 | -309.28 | 1,729.07 | 1,379.89 | -3,695.28 |
| Consensus Estimate | -4,487.19 | -3,509.00 | -3,159.25 | -2,904.23 | -2,843.23 | -2,724.34 | -2,431.34 | -2,268.54 | -289.36 | 1,829.07 | 1,468.18 | -3,577.80 |
Pull Wall Street consensus for Valion Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VBIO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VBIO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VBIO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();